SEARCH

SEARCH BY CITATION

Disclaimer: Supplementary materials have been peer-reviewed but not copyedited.

FilenameFormatSizeDescription
eji2261-sup-0001-s1.pdf755KSupporting Information Figure 1.DC phenotype upon activation with tumor-cell supernatants.
eji2261-sup-0001-s1.pdf755KSupporting Information Figure 2. Phenotype of IL-2-expanded lymphocytes.
eji2261-sup-0001-s1.pdf755KSupporting Information Figure 3.CD39/CD69 expression by non-Treg.
eji2261-sup-0001-s1.pdf755KSupporting Information Figure 4. Purity of isolated CD4+CD25+Treg.
eji2261-sup-0001-s1.pdf755KSupporting Information Figure 5. Effect of IDO inhibition on ACM-induced suppression of cytotoxicity.
eji2261-sup-0001-s1.pdf755KSupporting Information Figure 6. Cytokine production by T cells in DC cocultures.
eji2261-sup-0001-s1.pdf755KSupporting Information Figure 7. Enrichment of CD39/CD69-expressing Treg in the CD4+CD8+ doublet population.

Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.